Although we hypothesized that MET could improve memory dysfunction in Alzheimer’s disease patients by enhancing insulin sensitivity and signaling [26], we observed that chronic treatment with MET alone actually induced cognitive deficits in rodents [15]. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.